The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk
Abstract
AIMS: Circulating progenitor cells are believed to participate in cardiovascular (CV) homeostasis and their exhaustion has been linked to CV damage. As general agreement on their characterization is lacking, this work was carried out to assess the relationships between different antigenic profiles of progenitor cells and CV risk, with special regard to metabolic syndrome (MetSyn). METHODS AND RESULTS: CD34, CD133, and KDR were used to quantify circulating progenitors in 214 subjects at different levels of CV risk. In a cross-analysis of six different cell subtypes (CD34(+), CD133(+), CD34(+)CD133(+), CD34(+)KDR(+), CD133(+)KDR(+), and CD34(+)CD133(+)KDR(+)), CD34(+) progenitors showed the best correlation with CV parameters and risk estimates. Components of the MetSyn were all characterized by reduction of CD34(+) cells and acted synergistically in decreasing CD34(+) cell count. Moreover, CD34(+) cell count demonstrated a high performance in detecting high CV risk. CONCLUSION: These data demonstrate that CD34 identifies progenitor cells linked to CV risk, showing a close negative correlation between CD34(+) cells and CV risk, as well as a synergic detrimental effect of clustered metabolic components. Progenitor cell count may be used as a surrogate marker of CV risk, whereas extensive antigenic characterization may not be useful for this purpose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Circulating endothelial progenitor cells and cardiovascular outcomes
Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Böhm, M., & Nickenig, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043814 · Cited by 2,048
Cited by
Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
Fadini, G. P., Losordo, D., & Dimmeler, S. (2012) · Circulation Research · doi:10.1161/circresaha.111.243386 · Cited by 634
Self-citationEndothelial Dysfunction in Diabetes
Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., & Fadini, G. P. (2011) · Diabetes Care · doi:10.2337/dc11-s239 · Cited by 465
Self-citationHuman Endothelial Progenitor Cells
Yoder, M. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006692 · Cited by 397
Autologous stem cell therapy for peripheral arterial disease
Fadini, G. P., Agostini, C., & Avogaro, A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.033 · Cited by 257
Self-citationTechnical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau
Fadini, G. P., Baesso, I., Albiero, M., Sartore, S., Agostini, C., & Avogaro, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.039 · Cited by 253
Self-citation
Metadata
- Authors
- Fadini, G. P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-09
- Volume
- 27
- Issue
- 18
- Pages
- 2247-2255
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2164466232
- Cited by
- 235
- References
- 3
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. https://app.cochat.ai/papers/10.1093/eurheartj/ehl198
- The paper
- Fadini, G. P. (2006). Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. European Heart Journal. https://doi.org/10.1093/eurheartj/ehl198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.